CRYSTAL QUINONE PRIVATE LIMITED
@crystal_quinone_private_limited
Overview
About CRYSTAL QUINONE PRIVATE LIMITED
Crystal Quinone is a manufacturer of fine chemicals and specialty intermediates, serving global customers in the specialty chemicals, pigments, dyes and agrochemicals sectors since 1983.
We have progressively expanded our product range to include synthetic antioxidants (TBHQ, BHA), HPP and Azo pigment intermediates, specialty amines, vinyl sulfones, and sulfonamides. We also maintain local inventory in Antwerp, Belgium, enabling DDP deliveries across Europe.
In 2024, we commissioned a new manufacturing facility at Sayakha, Gujarat, dedicated to CDMO and synthesis of complex heterocyclic intermediates. This expansion reflects our increasing focus on strategic collaborations involving custom synthesis, process development, and scale-up support — particularly for customers seeking reliable partners for long-term, confidential manufacturing programs.
The company is promoted by Mr. Anang Shah and Mr. Aniket Shah, and is managed by a team of experienced professionals overseeing key functions across operations, R&D, quality, and commercial management. With a workforce of over 250 full-time employees, we emphasize both agility and consistency in delivering value to our customers.
We operate from regularly audited facilities that uphold stringent HSE and compliance standards, and we are certified under Ecovadis/TFS, ISO 45001, ISO 14001, BRC, and FAMIQS. Over the years, we’ve built strong expertise in technology transfer, product standardization, and co-development, often under NDAs with strategic global partners.
Our goal is to be a trusted global supplier of high-quality, niche chemical intermediates — combining manufacturing reliability with a growing capability in custom development and CDMO services.
We have progressively expanded our product range to include synthetic antioxidants (TBHQ, BHA), HPP and Azo pigment intermediates, specialty amines, vinyl sulfones, and sulfonamides. We also maintain local inventory in Antwerp, Belgium, enabling DDP deliveries across Europe.
In 2024, we commissioned a new manufacturing facility at Sayakha, Gujarat, dedicated to CDMO and synthesis of complex heterocyclic intermediates. This expansion reflects our increasing focus on strategic collaborations involving custom synthesis, process development, and scale-up support — particularly for customers seeking reliable partners for long-term, confidential manufacturing programs.
The company is promoted by Mr. Anang Shah and Mr. Aniket Shah, and is managed by a team of experienced professionals overseeing key functions across operations, R&D, quality, and commercial management. With a workforce of over 250 full-time employees, we emphasize both agility and consistency in delivering value to our customers.
We operate from regularly audited facilities that uphold stringent HSE and compliance standards, and we are certified under Ecovadis/TFS, ISO 45001, ISO 14001, BRC, and FAMIQS. Over the years, we’ve built strong expertise in technology transfer, product standardization, and co-development, often under NDAs with strategic global partners.
Our goal is to be a trusted global supplier of high-quality, niche chemical intermediates — combining manufacturing reliability with a growing capability in custom development and CDMO services.